CTLA4 and hematocrit: According to recent studies, the +49A/G CTLA-4 polymorphism has been demonstrated to link to Down syndrome disorders in HT patients (156), correlate with antithyroid antibody production in children with HT (157), and increase susceptibility and relapse of GD (158, 159).